Clinical trials: Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease

Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease

Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

• Completed
• Age: 20 years and older
• Phase 3
• Results posted

To evaluate the efficacy and safety of MT-6548 in peritoneal dialysis subjects with anemia associated with chronic kidney disease

Trial name

NCT03402386

Testing

MT-6548

Where

17 sites in Japan

Volunteers

42 people

Sponsor

Tanabe Pharma Corporation